Diana Hausman
2013 - Oncothyreon
In 2013, Diana Hausman earned a total compensation of $641.7K as Chief Medical Officer at Oncothyreon, a 8% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $96,787 |
---|---|
Option Awards | $189,000 |
Salary | $345,050 |
Other | $10,843 |
Total | $641,680 |
Hausman received $345.1K in salary, accounting for 54% of the total pay in 2013.
Hausman also received $96.8K in non-equity incentive plan, $189K in option awards and $10.8K in other compensation.
Rankings
In 2013, Diana Hausman's compensation ranked 8,478th out of 12,286 executives tracked by ExecPay. In other words, Hausman earned more than 31.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,478 out of 12,286 | 31st |
Division Services | 1,357 out of 1,938 | 30th |
Major group Engineering, Accounting, Research, Management, And Related Services | 115 out of 184 | 38th |
Industry group Research, Development, And Testing Services | 37 out of 63 | 41st |
Industry Commercial Physical and Biological Research | 37 out of 55 | 33rd |
Source: SEC filing on May 6, 2016.
Hausman's colleagues
We found four more compensation records of executives who worked with Diana Hausman at Oncothyreon in 2013.